75. Sci Rep. 2018 May 4;8(1):7047. doi: 10.1038/s41598-018-25526-1.All-trans-retinoic acid activates the pro-invasive Src-YAP-Interleukin 6 axis in triple-negative MDA-MB-231 breast cancer cells while cerivastatin reverses thisaction.Mezquita B(1)(2)(3), Mezquita P(3), Pau M(1), Gasa L(3), Navarro L(3), SamitierM(1), Pons M(4), Mezquita C(5).Author information: (1)Departament de Biomedicina, Laboratori de Genètica Molecular, Facultat deMedicina, Universitat de Barcelona, Barcelona, Spain.(2)Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona,Spain.(3)Departament de Ciències Bàsiques, Universitat Internacional de Catalunya,Barcelona, Spain.(4)Departament de Química Inorgànica i Orgànica, Secció de Química Orgànica,Laboratori de RMN de biomolècules, Universitat de Barcelona, Barcelona, Spain.(5)Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona,Spain. cmezquita@ub.edu.All-trans-retinoic acid (RA), the active metabolite of vitamin A, can reduce the malignant phenotype in some types of cancer and paradoxically also can promotecancer growth and invasion in others. For instance, it has been reported that RA induces tumor suppression in tumor xenografts of MDA-MB-468 breast cancer cellswhile increasing tumor growth and metastases in xenografts of MDA-MB-231 breastcancer cells. The signaling pathways involved in the pro-invasive action ofretinoic acid remain mostly unknown. We show here that RA activates thepro-invasive axis Src-YAP-Interleukin 6 (Src-YAP-IL6) in triple negativeMDA-MB-231 breast cancer cells, yielding to increased invasion of these cells. Onthe contrary, RA inhibits the Src-YAP-IL6 axis of triple-negative MDA-MB-468cells, which results in decreased invasion phenotype. In both types of cells,inhibition of the Src-YAP-IL6 axis by the Src inhibitor PP2 drastically reducesmigration and invasion. Src inhibition also downregulates the expression of apro-invasive isoform of VEGFR1 in MDA-MB-231 breast cancer cells. Furthermore,interference of YAP nuclear translocation using the statin cerivastatin reverses the upregulation of Interleukin 6 (IL-6) and the pro-invasive effect of RA onMDA-MB-231 breast cancer cells and also decreases invasion and viability ofMDA-MB-468 breast cancer cells. These results altogether suggest that RA induces pro-invasive or anti-invasive actions in two triple-negative breast cancer celllines due to its ability to activate or inhibit the Src-YAP-IL6 axis in differentcancer cells. The pro-invasive effect of RA can be reversed by the statincerivastatin.DOI: 10.1038/s41598-018-25526-1 PMCID: PMC5935706PMID: 29728589 